97204 ⎘
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells Kidney, bladder
Methods of inhibiting unwanted cell proliferation using an antibody that binds to sonic hedgehog and inhibits hedgehog signaling
#302Endoglin antibodies
#303COMPOSITION AND METHOD FOR DIAGNOSIS OR DETECTION OF RENAL CANCER
#304Methods of treating acute myeloid leukemia by blocking CD47
#305Methods of treating pancreatic or liver cancer using hedgehog antagonists
#306Diagnostic composition and kit for renal cell carcinoma
#307Crystal structures and methods using same
#308NOVEL SERPENTINE TRANSMEMBRANE ANTIGENS EXPRESSED IN HUMAN CANCERS AND USES THEREOF
#309PROCESS FOR ANTIBODY PRODUCTION
#310Anti-FGFR3 antibodies and methods using same
#311HUMAN ANTIBODIES THAT HAVE MN BINDING AND CELL ADHESION-NEUTRALIZING ACTIVITY
#312Detection of CXADR protein for diagnosis of kidney cancer
#313Humanized GM-CSF antibodies
#314Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer
#315KID31 and antibodies that bind thereto
#316N-cadherin: target for cancer diagnosis and therapy
#317ANTIBODIES AGAINST A PROTEIN ENTITLED 161P2F10B
#318PROTEINS
#319PROTEINS
#320Protein
#321Co-administration of CG250 and IL-2 or IFN-alpha for treating cancer such as renal cell carcinomas
#322Hybridoma cell line G250 and its use for producing monoclonal antibodies
#323Human GM-CSF antibodies
#324NUCLEIC ACID AND CORRESPONDING PROTEIN NAMED 158P1D7 USEFUL IN THE TREATMENT AND DETECTION OF BLADDER AND OTHER CANCERS
#325Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof
#326Non-functional P2Xreceptor
#327Methods for diagnosing and treating kidney cancer
#328PSCA: prostate stem cell antigen and distinguishing androgen receptor negative prostate cancer from benign prostatic hyperplasia
#329Cancer Antigen Mage-A9 and Uses Thereof
#330Methods for inhibiting the growth of cancer cells expressing PSCA
#331Methods for Discovering Antibodies Specific to Cancer Cells and Antibodies Discovered Thereby
#332Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity
#333Hybridoma cell line G250 and its use for producing monoclonal antibodies
#334Antibodies to non-functional P2Xreceptor
#335Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer
#336Methods for diagnosing and treating kidney cancer
#337Novel serpentine transmembrane antigens expressed in human cancers and uses thereof
#338Serpentine transmembrane antigens expressed in human cancers and uses thereof
#339Cancer specific monoclonal antibodies
#340Antibodies and related molecules that bind to 161P2F10B proteins
#341KID31 and antibodies that bind thereto
#342Bladder matrix protein peptides and methods of detection of bladder cancer
#343Fusion proteins of humanized g250 specific antibodies and uses thereof
#344Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity
#345Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer
#346Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer
#347Co-administration of cG250 and IL-2 or IFN-α for treating cancer such as renal cell carcinomas
#348Monoclonal antibodies directed to receptor protein tyrosine phosphatase zeta
#349Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers
#350PSCA: prostate stem cell antigen and uses thereof in pancreatic cancer
#351Mouse prostate stem cell antigen and uses thereof
#352Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof
#353Serpentine transmembrane antigens expressed in human cancers and uses thereof
#354PSCA: prostate stem cell antigen and uses thereof
#355Humanised antibodies and uses thereof
#356PSCA: prostate stem cell antigen and uses thereof